Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivermectin nasal spray for post-COVID-19 anosmia
NCT04951362Phase 3Unknown
- Sponsor
- South Valley University
- Start
- Apr 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ivermectin in anosmia (2 arms), sponsored by South Valley University. Primary endpoint: Regaining of smell at 2 weeks. Status: unknown.
02
Drugs
ivermectin
03
Conditions
anosmia
Beyond the preview
Go deeper on NCT04951362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04951362.